L F Brown Selected Research

L F Brown Research Topics

6	Neoplasms (Cancer) 06/2001 - 01/2000
3	Hemangiosarcoma (Angiosarcoma) 06/2000 - 04/2000
2	Hemangioma (Angioma) 12/2001 - 04/2000
2	Edema (Dropsy) 03/2001 - 01/2000
1	Vascular Malformations 01/2002
1	Carcinogenesis 06/2001
1	Atherosclerosis 02/2001
1	Sarcoma (Soft Tissue Sarcoma) 01/2001
1	Myxoid Liposarcoma 01/2001
1	Wounds and Injuries (Trauma) 07/2000
1	Acquired Immunodeficiency Syndrome (AIDS) 06/2000
1	Aicardi Syndrome 06/2000
1	Kaposi Sarcoma (Kaposi's Sarcoma) 06/2000
1	Ischemia 01/2000
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2000

10	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2002 - 01/2000
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 12/2001 - 04/2000
2	Angiopoietin-2IBA 12/2001 - 06/2000
2	Angiopoietin-1IBA 12/2001 - 06/2000
2	AngiopoietinsIBA 12/2001 - 06/2000
2	Messenger RNA (mRNA)IBA 12/2001 - 01/2001
2	Angiogenesis InhibitorsIBA 06/2001 - 07/2000
2	Angiogenesis Inducing Agents (Angiogenesis Factor)IBA 06/2001 - 04/2000
2	FibrinIBA 03/2001 - 01/2000
2	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 04/2000 - 01/2000
1	Proteins (Proteins, Gene)FDA Link 12/2001
1	LigandsIBA 12/2001
1	Biological ProductsIBA 06/2001
1	ThymosinIBA 02/2001
1	MucinsIBA 01/2001
1	matrigelIBA 01/2001
1	Thrombospondin 1IBA 07/2000
1	angiopoietin 4IBA 06/2000
1	TIE Receptors (TIE Receptor Tyrosine Kinases)IBA 06/2000
1	Tumor Viral Antigens (Large T Antigen)IBA 04/2000
1	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 04/2000
1	CytokinesIBA 01/2000

1	Subcutaneous Injections 01/2000